Allied And Radient Join Dhaliwal Group To Supply CBD Products To Canada

Medical cannabis company Allied Corp. ALID and Radient Technologies Inc. (OTC: RDDTF) are teaming up with Dhaliwal Group to run the supply chain, production and sale of CBD distillate and isolate.

The agreement, reported Wednesday, will require Allied to manage supply and purchase operations between licensed growers and licensed purchasers while Radient will be in charge of transforming industrial hemp biomass into final CBD consumer products. Those products will then be sold into the Canadian market via a purchasing deal made by Dhaliwal.

Furthermore, Allied will take over complete supply chain management.

The agreement is set for 12 months, with an option to renew. Up to 7,500 kilograms of biomass is projected to be processed in the first three months of the agreement.

“This is a significant milestone achievement for Allied’s 5th vertical – facilitation of the Canadian and European cannabis product supply chain,” Allied CEO Calum Hughes said in a statement. ”Retailers are currently facing a challenging environment in receiving quality product.”

Radient President and CEO Denis Taschukalso also commented on the collaboration.

“Radient is very pleased to enter into this Agreement with Allied and the Dhaliwal Group," Taschukalso said. "This Agreement will allow us to create the high quality products that our proprietary continuous-flow extraction and processing technology was intended for."

Related Links:

University Of Haifa Greenlights PTSD And Cannabis Pre-Clinical Study

These Were The Companies Added And Removed From OTC Markets Indexes At The End Of Q3

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsMarketsCBD
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.